Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Therapeutic Drug Carrier Systems
IF: 2.9 5-Year IF: 3.72 SJR: 0.736 SNIP: 0.818 CiteScore™: 4.6

ISSN Print: 0743-4863
ISSN Online: 2162-660X

Volumes:
Volume 37, 2020 Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.2013007236
pages 331-368

Nanocurcumin: A Promising Therapeutic Advancement over Native Curcumin

Gagan Flora
School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, M.P., India
Deepesh Gupta
School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, M.P., India
Archana Tiwari
School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, M.P., India

ABSTRACT

Curcumin, a naturally occurring polyphenolic compound, is known to have a wide range of therapeutic and pharmacological properties. Although it is a considerably promising compound, its poor water solubility and fast degradation profile make it compromise over its bioavailability way below the threshold level on administration. Over a period of time, a lot of emphasis has been given to improve the biodistribution of native curcumin, but it is only recently that the application of the field of nanotherapeutics has significantly improved its therapeutic efficacy. This is through the development of nanorange formulations of curcumin, popularly known as the "nanocurcumin." These attempts have given a strong platform to reap all the biological benefits from this phytodrug, which was not significantly plausible earlier. This review gives an insight into the reasons that make nanocurcumin a more therapeutically advanced drug than its native counterpart. It also discusses various nanometric formulations of curcumin that have been reported for its controlled and targeted delivery along with a critical comparison of its therapeutic efficacy with free curcumin. We also summarize the biological applications, patented technologies, and current status of the ongoing clinical trials related to nanocurcumin.


Articles with similar content:

Emerging Trends in Non-Interferon-Based Genotype-Specific Antiviral Agents: Pharmaceutical Perspectives
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 4
Tahir Farooq, Muhammad Ibrahim, Tahsin Gulzar, Matloob Ahmed, Muhammad Sajid Hamid Akash, Arruje Hameed, Kanwal Rehman
Nanomedicines for Treatment of Viral Diseases
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.30, 2013, issue 1
Medha Joshi, Vandana B. Patravale, Rujuta Mehendale
Antiretroviral Agents: Looking for the Best Possible Chemotherapeutic Options to Conquer HIV
Critical Reviews™ in Eukaryotic Gene Expression, Vol.26, 2016, issue 4
Tahir Farooq, Muhammad Ibrahim, Muhammad Imran Qadir, Muhammad Sajid Hamid Akash, Kanwal Rehman, Arruje Hameed
Mucoadhesion and the Gastrointestinal Tract
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.25, 2008, issue 3
Joao J. S. Sousa, Abdul W. Basit, Emma L. McConnell, Felipe J. O. Varum, Francisco Veiga
Conundrum and Therapeutic Potential of Curcumin in Drug Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.27, 2010, issue 4
Javed Ali, Sanjula Baboota, Anil Kumar, Alka Ahuja